European Investor
13 Oct 2026, 15:09
UnitedHealth Slips 0.5% Despite Higher Profitability and Improved Medical Cost Trends
UnitedHealth Group (NYSE: UNH) shares fell about 0.5% even after the company reported stronger third-quarter profitability and improved medical cost performance.
Third-quarter adjusted earnings were $4.69 per share. Revenue came in at $112.7 billion, slightly below the $113.2 billion reported a year earlier, but operating earnings increased sharply to $6.6 billion from $4.3 billion.
A key positive was the medical care ratio, which improved to 88.4% from 89.9% a year ago. UnitedHealth attributed the decline to better medical cost management, benefit design changes, pricing discipline and care delivery improvements. The quarter also benefited from $610 million of favorable prior-period reserve development related to 2026 dates of service.
UnitedHealthcare served 48.3 million consumers and generated $86.3 billion in revenue and $2.8 billion in earnings. Optum reported $66.9 billion in revenue and $3.7 billion in earnings while serving more than 120 million patients and consumers.
Operating efficiency also improved, with the operating cost ratio declining to 12.8% from 13.5% a year earlier. Cash flow from operations totaled $5.1 billion, or 1.2 times net income.
The company updated its full-year 2026 outlook to earnings of at least $19.50 per share and adjusted earnings of at least $20.50 per share.
The modest decline in UnitedHealth shares suggests investors may be focusing on the slight year-over-year revenue contraction and the fact that part of the medical ratio improvement came from favorable reserve development, despite stronger operating earnings and better cost control.
UnitedHealth Group (NYSE: UNH) shares fell about 0.5% even after the company reported stronger third-quarter profitability and improved medical cost performance.
Third-quarter adjusted earnings were $4.69 per share. Revenue came in at $112.7 billion, slightly below the $113.2 billion reported a year earlier, but operating earnings increased sharply to $6.6 billion from $4.3 billion.
A key positive was the medical care ratio, which improved to 88.4% from 89.9% a year ago. UnitedHealth attributed the decline to better medical cost management, benefit design changes, pricing discipline and care delivery improvements. The quarter also benefited from $610 million of favorable prior-period reserve development related to 2026 dates of service.
UnitedHealthcare served 48.3 million consumers and generated $86.3 billion in revenue and $2.8 billion in earnings. Optum reported $66.9 billion in revenue and $3.7 billion in earnings while serving more than 120 million patients and consumers.
Operating efficiency also improved, with the operating cost ratio declining to 12.8% from 13.5% a year earlier. Cash flow from operations totaled $5.1 billion, or 1.2 times net income.
The company updated its full-year 2026 outlook to earnings of at least $19.50 per share and adjusted earnings of at least $20.50 per share.
The modest decline in UnitedHealth shares suggests investors may be focusing on the slight year-over-year revenue contraction and the fact that part of the medical ratio improvement came from favorable reserve development, despite stronger operating earnings and better cost control.
